Delivery Order SPE2DX22D0029-SPE2D824F46RF

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $60K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for pharmaceutical and medical supply products provided by Amerisourcebergen Drug Corp to the U.S. government. The award, valued at $12,775.20, is a Firm Fixed Price Delivery Order contract with the Defense Logistics Agency (DLA) Troop Support Medical, a major customer for Amerisourcebergen. The contract has a period of performance ending on October 1, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of pharmaceutical and medical supplies to support the U.S. government's healthcare programs. The contract, valued at $214,553.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 4, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs)...
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $57,564.93, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of medical commodities, including prescription medications,...
This federal contract award is for the delivery of pharmaceutical products and medical supplies by AmerisourceBergen Drug Corp's Corporate Office division to the U.S. government. The contract, valued at $3,193.80, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of AmerisourceBergen. The contract is a delivery order issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently...
This federal contract award is for pharmaceutical and medical supply products provided by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $37,832.22, is a Delivery Order contract with the Defense Logistics Agency (DLA) Troop Support Medical. It has an ultimate completion date of January 22, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a Delivery Order valued at $9,195.00. The contract is for the supply of a variety of pharmaceutical products and medical supplies to support military treatment facilities and federal healthcare programs. As a large Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award is for Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply a broad range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $99,754.87, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of April 29, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of various pharmaceutical products and medical supplies to support the U.S. government's medical requirements. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $1,345.86 and a completion date of August 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award to AmerisourceBergen Drug Corp is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The contract is for the supply of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The delivery order has a ceiling value of $1,054.90 and a firm fixed-price pricing...
  • SPE2DX22D0029
    Indefinite Delivery Contract
  • SPE2DX22D0029-SPE2D824F46RF
    Delivery Order

This federal contract award is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $59,512.32, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999 through December 2025, enabling the DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by September 12, 2024. AmerisourceBergen's federal contracting activities primarily involve supplying essential pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, medical supplies, and equipment, to various government agencies and healthcare programs.

Generated 12/11/24, 9:36 AM